En Español

CRITERIA FOR EVALUATION OF CLINICAL PROGRESS

1) Decrease of pain, indicated by a decrease in the amount or frequency of the use of narcotics or sedatives.
2) Increase in the sense of well being.
3) Increased appetite.
4) Disappearance of fetor from lesions.
5) Increased energy or endurance.
6) Increase in weight.
7) Increase in muscle strength.
8) Improvement in blood and urine chemistry.
9) Increased tissue repair.
10) Decrease of tumefaction.
11) Decrease in the output of presumptive chorionic gonadotrophin in the serum or urine as measured by a blood test.
12) Return of symptoms following the use of placebos or interruption of treatment.
13) Remission of symptoms follows the reinstatement of therapy.


More on B17...

Introduction
Important Warning
About Vitamin B17
Vitamin B17 as Preventative
Metabolic Therapy in Cancer
B17 in Metabolic Therapy
Laetrile and Cyanide
Graphic on Action of B17
Frequently Asked Questions
B17 Therapy components
Accessory Supplements
B17 Therapy Overview
Therapies and Protocols
What is in B17 Therapy?
Maintenance Dosages
Accessory Therapies
Positive Thinking
Implementing Changes
Behaviour of tumours
Criteria for Evaluation
B17 - Sickle Cell Anaemia
Fluoridation-linked Cancer
Contacts
In God We Trust
References

More Studies, Research,

Documented Evidence







©Copyright 2000 - Worldwithoutcancer.org.uk - PO Box 2038 - Leigh-on-Sea - SS9 2ZB - UK
Disclaimer About Us Products Contact Us
Home